title: [The treatment of patients with refractory forms of Hodgkin's lymphomas].
abstract: The treatment of patients with refractory forms of Hodgkin's lymphomas in combination with chemo-radiotherapy is priority. Nevertheless, chemotherapy has to include multicomponent schemes and radiation therapy should be an addition and consolidative method to chemotherapy.
authors.forename: H O
authors.initials: HO
authors.lastname: Hubareva
authors.forename: I A
authors.initials: IA
authors.lastname: Kriachok
authors.forename: I B
authors.initials: IB
authors.lastname: Tytorenko
authors.forename: O M
authors.initials: OM
authors.lastname: Aleksyk
authors.forename: O I
authors.initials: OI
authors.lastname: Novosad
authors.forename: T V
authors.initials: TV
authors.lastname: Kadnikova
authors.forename: A V
authors.initials: AV
authors.lastname: Martynchyk
authors.forename: Ia V
authors.initials: IaV
authors.lastname: Pastushenko
authors.forename: K S
authors.initials: KS
authors.lastname: Filonenko
authors.forename: Ie V
authors.initials: IeV
authors.lastname: Kushchevyĭ
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D012307:Risk Factors; D055815:Young Adult